未知生产厂商
TMV-083 is an attenuated live virus COVID-19 vaccine candidate which employs the measles vaccine as a vector. It expresses a spike protein antigen from SARS-CoV-2.
TMV-083 is an attenuated live virus COVID-19 vaccine candidate which employs the measles vaccine as a vector. It expresses a spike protein antigen from SARS-CoV-2.
